Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Post by Chopper1BigDogon Feb 20, 2021 3:28pm
221 Views
Post# 32619440

Idexx / zom / lex

Idexx / zom / lex IDEXX offers point-of-care diagnostics through multiple systems, with the most notable being the "Catalyst One" platform. The Catalyst One platform currently offers in-office diagnostics of 34 chemistry, electrolyte, and immunoassay profiles. This includes thyroid diagnostics, which would directly compete with the TRUFORMA launch. IDEXX operates globally, and as of Q3 2020 estimates that they are currently meeting ~5% of the global total addressable market for companion animal diagnostics.
LexaGene offers the MiQLab system, which includes rapid point-of-care pathogen detection. While this is a cartridge-based system like TRUFORMA and Catalyst One, it currently focuses on bacterial infection diagnoses and antibiotic resistance markers.
For larger clinics, Siemens offers the Immulite 1000 immunoassay system. This is less focused on point-of-care veterinary applications, but is highly accurate and was used as the baseline against which ZOM verified the TRUFORMA platform.
<< Previous
Bullboard Posts
Next >>